Jutta Proba

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

Dissecting cell identity via network inference and in silico gene perturbation

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias